Sorted By:

Relevance


The Value of Innovation in Oncology

PhRMA  |  Report

A new white paper by Boston Healthcare Associates examines how innovative medicines are driving significant progress in the fight against cancer. Though initial approval by the U.S. Food and Drug Administration is a tremendous milestone, ongoing research and accumulation of knowledge reveals bene...
https://www.phrma.org/report/the-value-of-innovation-in-oncology

Impact of the Health Insurance Marketplace on Participant Cost Sharing for Pharmacy Benefits

Access Better Coverage  |  From Our Network

This report details Milliman's analysis and the methodology used to develop these conclusions.
http://www.accessbettercoverage.org/reports/impact-of-the-health-insurance-marketplace-on-participant-cost-sharing-for-pharmacy-benefits

2015 PhRMA Profile: Annual Membership Survey Results

PhRMA  |  Report

R&D Expenditures: Expenditures within PhRMA member companies’ US and/or foreign research laboratories plus research and development (R&D) funds contracted or granted to commercial laboratories, private practitioners, consultants, educational and nonprofit research institutions, manufacturing a...
https://www.phrma.org/report/2015-phrma-profile-annual-membership-survey-results

A Decade of Innovation in Cancer

PhRMA  |  Report

Cancer, in its many forms, has long been one of the most devastating and confounding health concerns worldwide. Characterized by the uncontrolled growth and spread of abnormal cells, cancers wreak havoc on the body and, if left unchecked, can lead to malfunction of various health systems ...
https://www.phrma.org/report/a-decade-of-innovation-in-cancer

The Global Economic Cost of Cancer

PhRMA  |  Report

Cancer is taking an enormous human toll around the world and is a growing threat in low- to middle-income countries. And little has been known about what that toll means in dollars, until now....
https://www.phrma.org/report/the-global-economic-cost-of-cancer

PhRMA Supports President’s Commission’s Holistic Approach on Opioid Crisis

PhRMA  |  Blog Post

We applaud the Commission’s engagement with our nation’s governors and others from around the country who are on the front lines of this crisis to inform the report recommendations. 
http://catalyst.phrma.org/phrma-supports-presidents-commissions-holistic-approach-on-opioid-crisis

Biopharmaceutical Industry Speakers List

PhRMA  |  Report

The Biopharmaceutical Industry Speakers List contains names of executives at the Pharmaceutical Research and Manufacturers of America (PhRMA) and its member companies available to participate in events and panel discussions on the cost and value of prescription medicines. A photo, biography and c...
https://www.phrma.org/report/biopharmaceutical-industry-speakers-list

List of 2015 Medicines in Development for Heart Disease and Stroke

PhRMA  |  Report

The List of 2015 Medicines in Development for Heart Disease and Stroke Report outlines the medicines in development, including its product name, sponsor, indication and development status, for the following cardiovascular diseases: Acute Coronary Syndrome, Adjunctive Therapies, Arrhythmia/Atrial Fibrillation, Atherosclerosis, Cardiomyopathy, Coronary Artery Disease, Heart Attack, Heart Failure, Hypertension, Lipid Disorders, Peripheral Vascular Disease, Pulmonary Vascular Disease, Stroke, and Thrombosis.
https://www.phrma.org/report/list-of-2015-medicines-in-development-for-heart-disease-and-stroke

Cost-Sharing Reductions Unevenly Applied Across Services in Exchange Plans

Access Better Coverage  |  From Our Network

Specifically, the data show broad differences in how issuers amend plan designs to meet cost- sharing requirements for those receiving cost -sharing reductions (CSR). While almost all plans reduce deductibles and out-of-pocket caps in CSR plans, many plans do not lower cost-sharing for other trea...
http://www.accessbettercoverage.org/reports/cost-sharing-reductions-unevenly-applied-across-services-in-exchange-plans

Chart Pack: Biopharmaceuticals in Government Programs

PhRMA  |  Report

This chart pack features key facts about prescription medicines in four major government programs—Medicare, Medicaid, the US Department of Veterans Affairs (VA), and the 340B program. Medicare insures many of the nation’s retirees and disabled persons and covers medicines primarily through Part D...
https://www.phrma.org/report/chart-pack-biopharmaceuticals-in-government-programs

Biopharmaceuticals in Perspective: Chart Pack 2013

PhRMA  |  Report

This chart pack provides facts and figures about prescription medicines and their role in the health care system. Topics include medicines’ impact on health and quality of life, the drug discovery and development process, biopharmaceutical spending and costs, the challenge of treatment gaps and i...
https://www.phrma.org/report/biopharmaceuticals-in-perspective-chart-pack-2013

Innovation in the Biopharmaceutical R&D Process – Adapting to a Changing Environment

PhRMA  |  Report

This backgrounder looks at the strategies and tactics biopharmaceutical companies have implemented to adapt to evolving trends in the research and development (R&D) process. While the last five years have been among the most productive in history for new drug approvals and innovation, this remark...
https://www.phrma.org/report/innovation-in-the-biopharmaceutical-randd-process-adapting-to-a-changing-environment

Researching Cancer Medicines: Setbacks and Stepping Stones

PhRMA  |  Report

A cancer diagnosis can be devastating to individuals faced with the disease, along with their families and caregivers supporting them in their fight. While recent scientific advances have led to improved prevention, earlier diagnoses, and innovative treatments for many cancers, there is still tre...
https://www.phrma.org/report/researching-cancer-medicines-setbacks-and-stepping-stones

Researching Alzheimer’s Medicines: Setbacks and Stepping Stones

PhRMA  |  Report

Alzheimer’s disease is a devastating disease that causes individuals to lose their memories, independence, relationships, and, ultimately, their lives. Family and caregivers face many challenges as they care for a loved one who is gradually slipping away. From a societal perspective, Alzheimer’s ...
https://www.phrma.org/report/researching-alzheimer-s-medicines-setbacks-and-stepping-stones

Manager - Public Affairs

PhRMA  |  PhRMA Career

Create agendas, presentation materials and summary/compilation reports.
https://www.phrma.org/careers/manager-public-affairs

Zika Virus: Current Outbreak and Ongoing Research Efforts

PhRMA  |  Report

The Zika virus is a tropical, mosquito-borne illness that is transmitted after being bitten by the Aedes mosquito – the same type of mosquito that spreads Dengue, Chikungunya, and Yellow Fever. Symptoms of the disease are usually mild, including fever, joint pain, rashes, and viral conjunct...
https://www.phrma.org/report/zika-virus-current-outbreak-and-ongoing-research-efforts

Medicare Part D Pocket Card

PhRMA  |  Report

Medicare Part D, the outpatient prescription drug benefit, provides seniors and individuals with disabilities access to affordable prescription drug coverage. Part D allows beneficiaries to choose from a range of private plans that best meet their needs. Now, 90% of Medicare beneficiaries receive...
https://www.phrma.org/report/medicare-part-d-pocket-card

Achieving Optimal Value from Medicines

PhRMA  |  Report

This presentation explores the opportunities and barriers for better use of medicines, the clinical and economic benefits to medicine adherence, and how adherence to medicines affects high cost sharing....
https://www.phrma.org/report/achieving-optimal-value-from-medicines

Driving Innovation and Economic Growth for the 21st Century

PhRMA  |  Report

This report details the continuing rise of state policies and programs to attract, retain, and grow an innovative biopharmaceutical presence.
https://www.phrma.org

Clinical Trials Awareness Week Toolkit

PhRMA  |  Report

Also, many participants report great satisfaction in playing a key role in advancing medical science and helping scientists find new treatments that will help more people live longer, healthier lives.
https://www.phrma.org/report/clinical-trials-awareness-week-toolkit

Medicamentos en Desarrollo para la Diabetes

PhRMA  |  Report

La epidemia de diabetes en los Estados Unidos afecta a millones de estadounidenses, con 1,4 millones de casos nuevos diagnosticados cada año. Para muchos pacientes, un diagnóstico de diabetes afecta casi todos los aspectos de, su vida, incluidas las preocupaciones de una dieta especial y otros ca...
https://www.phrma.org/report/medicamentos-en-desarrollo-para-la-diabetes

Biopharmaceutical Research & Development: The Process Behind New Medicines

PhRMA  |  Report

Biopharmaceutical research companies invest considerable resources to move an investigational medicine through the complex and lengthy research and development process. This brochure delves into the scientific, technical, and regulatory challenges companies face as they work to deliver innovative...
https://www.phrma.org/report/biopharmaceutical-research-and-development-the-process-behind-new-medicines

Recognizing the Value of Innovation in Rheumatoid Arthritis

PhRMA  |  Report

Significant progress has been made in recent years in our ability to diagnose and treat rheumatoid arthritis (RA), a devastating autoimmune disease that causes progressive joint deterioration and pain in millions of Americans. Therapeutic advances have transformed the RA treatment paradigm over t...
https://www.phrma.org/report/recognizing-the-value-of-innovation-in-rheumatoid-arthritis

Medicare Monday: Catch up on MedPAC and its Part B recommendations

PhRMA  |  Blog Post

For policy wonks, you can get up to speed with our Memorial Day reading list on the Medicare Payment Advisory Commission (MedPAC), how it informs Medicare policy and its recent Part B recommendations, which are expected to be included in their report to Congress this June.
http://catalyst.phrma.org/medicare-monday-catch-up-on-medpac-and-its-part-b-recommendations

Glossary of Terms - Rare Diseases

PhRMA  |  Report

acquired immune deficiency syndrome (AIDS)—A manifestation of infection with the human inimunodeficiency virus (HIV) characterized by the presence of one or more opportunistic diseases which occur primarily, or in some cases only, when an individual’s immune system function is de...
https://www.phrma.org/report/glossary-of-terms-rare-diseases

You have reviewed the first 250 results out of 1029. Each page contains 25 results. You're on page 10.

prev 7 8 9 10 11 12 next